Why are bioassays crucial for regulatory submissions?

Bioassays provide measurable data regarding drug efficacy and safety, which are paramount for regulatory agencies tasked with protecting public health.

What are the consequences of inadequate bioassay validation?

Inadequate validation can lead to regulatory rejections, delays in product launches, and potential harm to patients due to unreliable data.

How does InfinixBio support bioassay validation?

At InfinixBio, we offer comprehensive support including assay development, validation services, and consultation on regulatory submissions to ensure your bioassays meet the stringent requirements set by regulators.

Are there specific guidelines for bioassay validations?

Yes, regulatory organizations like the FDA and EMA provide guidelines outlining the essential criteria for bioassay validations, which must be thoroughly adhered to during the submission process. For a broader perspective on these, check out our insights on regulatory submissions.